Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OCS
OCS logo

OCS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OCS News

Oculis Receives EMA PRIME Designation for Privosegtor

1d agoNewsfilter

Oculis Secures PRIME Designation for Privosegtor, Advancing Development

1d agoYahoo Finance

Oculis Announces Upcoming Investor Conference Schedule

Mar 05 2026Newsfilter

Oculis Reports 2025 Financial Results and Clinical Milestones

Mar 04 2026NASDAQ.COM

Oculis Holding Reports Q4 Earnings Beat Expectations

Mar 03 2026seekingalpha

Oculis Appoints New Chief Legal Officer to Enhance Leadership

Feb 17 2026Newsfilter

Oculis Receives FDA Breakthrough Therapy Designation, Potential Market Exceeds $7 Billion

Jan 08 2026Globenewswire

Oculis Receives FDA Breakthrough Therapy Designation, Potential Market Exceeds $7 Billion

Jan 08 2026Globenewswire

OCS Events

03/04 16:30
Oculis Files Automatic Mixed Securities Shelf
Oculis files automatic mixed securities shelf

OCS Monitor News

No data

No data

OCS Earnings Analysis

No Data

No Data

People Also Watch